Encompass Health (NYSE:EHC – Get Free Report) and Basel Medical Group (NASDAQ:BMGL – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.
Risk and Volatility
Encompass Health has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Basel Medical Group has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500.
Institutional & Insider Ownership
97.3% of Encompass Health shares are owned by institutional investors. 1.8% of Encompass Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Encompass Health | $5.94 billion | 2.05 | $566.20 million | $6.14 | 20.13 |
| Basel Medical Group | $8.90 million | 0.94 | -$9.50 million | N/A | N/A |
Encompass Health has higher revenue and earnings than Basel Medical Group.
Profitability
This table compares Encompass Health and Basel Medical Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Encompass Health | 10.01% | 18.08% | 8.22% |
| Basel Medical Group | N/A | N/A | N/A |
Analyst Ratings
This is a breakdown of recent ratings and price targets for Encompass Health and Basel Medical Group, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Encompass Health | 0 | 1 | 7 | 1 | 3.00 |
| Basel Medical Group | 1 | 0 | 0 | 0 | 1.00 |
Encompass Health presently has a consensus target price of $148.71, indicating a potential upside of 20.34%. Given Encompass Health’s stronger consensus rating and higher possible upside, equities analysts clearly believe Encompass Health is more favorable than Basel Medical Group.
Summary
Encompass Health beats Basel Medical Group on 13 of the 13 factors compared between the two stocks.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
About Basel Medical Group
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
